Condition
Lung Cancer Survivors
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Questionnaires Or Telephone Interview
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT00582348CompletedPrimary
Physical Activity and Inactivity in Lung Cancer Survivors
NCT00586937CompletedPrimary
Quality of Life in Lung Cancer Survivors
Showing all 2 trials
Research Network
Common Treatments
- Questionnaires Or Telephone Interview1
Active Sponsors
- Memorial Sloan Kettering Cancer Center2
- Fox Chase Cancer Center1
- National Institutes of Health (NIH)1
Top Investigators
Memorial Sloan Kettering Cancer Center